MAPLAB
LIVE

Serial Number

98188329

Owner

Komodo Health, Inc.

Attorney

Jordan A. LaVine

First Use Date

Sep 23, 2023

Filing Date

Sep 20, 2023

Add to watchlist:

No watchlists yet
View on USPTO

MAPLAB Trademark

Serial Number: 98188329 • Registration: 7616057

MAPLAB is a trademark filed by Komodo Health, Inc. on September 20, 2023. The trademark is classified under Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Komodo Health, Inc. (26 trademarks)

680 Folsom Street, 5th Floor
San Francisco, CA 94107

Entity Type: 03

Trademark Details

Filing Date

September 20, 2023

Registration Date

December 17, 2024

First Use Anywhere

September 23, 2023

First Use in Commerce

September 23, 2023

Published for Opposition

June 25, 2024

Goods & Services

Business data collection and analysis services in the field of healthcare, namely, aggregating, organizing and compiling of information, data, statistics, insights, metrics, profiles, analytics and intelligence on healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, care demographics, lab data, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications, all of the foregoing excluding psychedelic medicines and therapies; business consulting and analysis services regarding information, data, statistics, insights, metrics, profiles, analytics and intelligence on healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, care demographics, lab data, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications, all of the foregoing excluding psychedelic medicines and therapies; Providing business information in the field of the healthcare and life sciences industries, all of the foregoing excluding psychedelic medicines and therapies; Business consulting services to businesses in the healthcare and life sciences industries, all of the foregoing excluding psychedelic medicines and therapies

Platform-as-a-service (PaaS) featuring computer software platforms that allows organizations and stakeholders in healthcare viewing of a database with information, data, statistics, insights, metrics, profiles, analytics and intelligence on healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, care demographics, lab data, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications, all of the foregoing excluding psychedelic medicines and therapies; platform-as-a-service (PaaS) featuring computer software platforms that allows organizations and stakeholders in healthcare the ability to model patient journeys, pathways, and care programs, all of the foregoing excluding psychedelic medicines and therapies; computer services, namely, database development services, namely, configuration and customization of databases containing information, data, statistics, insights, metrics, profiles, analytics and intelligence healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, lab data, care demographics, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications, all of the foregoing excluding psychedelic medicines and therapies; platform-as-a-service (paas) featuring computer software platforms that allow the viewing of market access insights to the life sciences industry, provide business solutions that unify pharmaceutical sales, operations, and marketing data, and provide data intelligence that aids with effective targeting, messaging, and initiatives driving sales performance, all of the foregoing excluding psychedelic medicines and therapies; Design, development and implementation of computer software for the healthcare and life sciences industry, namely, the design and development of cloud-based and application-based software for monitoring, marketing, and delivering products in the healthcare and life sciences industry, all of the foregoing excluding psychedelic medicines and therapies; Consulting services in the fields of selection, implementation and use of computer hardware and software systems for others in the health care and life science industries, all of the foregoing excluding psychedelic medicines and therapies; Business technology software consultation services in the health care and life science industries, all of the foregoing excluding psychedelic medicines and therapies; Software development and product development consulting in the field of the health care and life science industries, all of the foregoing excluding psychedelic medicines and therapies

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 17, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 17, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Nov 26, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Nov 26, 2024 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Nov 22, 2024 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 22, 2024 AITU
USE AMENDMENT FILED
Sep 18, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Sep 18, 2024 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 20, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 25, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jun 25, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 5, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 22, 2024 CNSA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
May 22, 2024 ZZZX
APPROVED FOR PUB - PRINCIPAL REGISTER
May 22, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
May 22, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 22, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
May 22, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 22, 2024 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 14, 2024 GNRN
NON-FINAL ACTION E-MAILED
May 14, 2024 GNRT
NON-FINAL ACTION WRITTEN
May 14, 2024 CNRT
ASSIGNED TO EXAMINER
May 14, 2024 DOCK
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Nov 1, 2023 TAEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Nov 1, 2023 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 5, 2023 NWOS
NEW APPLICATION ENTERED
Sep 23, 2023 NWAP